The latest closing stock price for CRISPR Therapeutics AG as of June 06, 2025 is 41.86.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $1,971 today, roughly 2 times their original investment - a 12.86% compound annual growth rate over 9 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 67.88, which is 62.2% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 30.04, which is 28.2% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 45.71.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $1,971 today, roughly 2 times their original investment - a 12.86% compound annual growth rate over 9 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 67.88, which is 62.2% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 30.04, which is 28.2% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 45.71.